Transplantation Direct (Apr 2019)

Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected

  • Nicholas Gilbo, MD,
  • Ina Jochmans, PhD,
  • Mauricio Sainz-Barriga, PhD,
  • Frederik Nevens, PhD,
  • Schalk van der Merwe, PhD,
  • Wim Laleman, PhD,
  • Chris Verslype, PhD,
  • David Cassiman, PhD,
  • Len Verbeke, PhD,
  • Hannah van Malenstein, PhD,
  • Tania Roskams, PhD,
  • Jacques Pirenne, PhD,
  • Diethard Monbaliu, PhD

DOI
https://doi.org/10.1097/TXD.0000000000000883
Journal volume & issue
Vol. 5, no. 4
p. e342

Abstract

Read online

Background. Older donors and recipients are increasingly considered for liver transplantation. Both donor and recipient age have a negative impact on outcomes. Large registry analyses show that older donors are frequently matched to older recipients. Whether age-related risks accumulate in a synergic negative effect on outcomes because of donor-recipient age matching is poorly understood. Methods. We investigated the impact of donor-recipient age interaction on patient and death-censored graft survival in multivariate Cox regressions in 849 transplants (January 2000 to December 2015). Results. Donors 70 years or older did not affect long-term patient or graft survival. Recipient age independently increased the risk of death (hazard ratio [HR], 1.03; 95% confidence interval [CI], 1.02-1.05, P < 0.0001), but donor-recipient age interaction was noninfluential. The negative impact of recipient age on patient survival was significant as early as 6 months after transplantation (HR, 1.06; 95% CI, 1.03-1.09; P = 0.00008). The adjusted risk of death was significant for patients aged 60 to 69 years (HR, 1.995; 95% CI, 1.40-2.85; P < 0.0001) and 70 years or older (HR, 2.001; 95% CI, 1.10-2.66; P = 0.04). In contrast, the risk of graft loss was not influenced by recipient age (HR, 1.02; 95% CI, 0.996-1.04; P = 0.11) or age interaction. Conclusions. Older livers can be safely used in older recipients without jeopardizing graft and patient survival if other risk factors are minimized.